TAG:
DarkDaily
November 7, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
Many experts were impressed when General Electric Co. ponied up $587 million to acquire pathology testing company Clarient, Inc., in October 2010. Now comes further insight behind this transaction. At an investment conference in Boston on November 3, John Dineen, CEO…
Congress Likely to Pass Deep Cuts in Lab Test Fees
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
CEO SUMMARY: All signs point to a potentially dismal financial outcome for the clinical lab testing industry as Congress tries to trim spending by $1.2 trillion over the next 10 years. At least three proposals to significantly cut lab test reimbursement are in active debate by fe…
October 17, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
Have you ever heard the term “digital PCR” (Polymerase Chain Reaction)? That technology was of such interest to Bio-Rad Laboratories, Inc., that it just paid $162 million to acquire QuantaLife, Inc., the company that developed this digital PCR technology. The dea…
September 26, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
Here’s a laboratory with what may be one of the world’s biggest accounts receivable problems. In South Africa, the National Health Laboratory Services (NHLS) says it is owed $1.8 billion Rand (about US $214 million) from its client accounts. As reported by a regional television s…
September 6, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 12 – September 6, 2011 Issue
Cleveland Heart Lab closed on a Series B financing round that totals $18.4 million. The money was provided by Excel Venture Management, Healthcare Ventures, and existing investors. Executives at Cleve- land Heart Lab said the new funds will be used t…
Congress Again Considers Co-Insurance for Lab Tests
By Robert Michel | From the Volume XXVIII No. 11 – August 15, 2011 Issue
CEO SUMMARY: Congressional cost-cutters are putting the 20% patient co-pay/coinsurance requirement for lab testing back on the table. The added complication this year is that the new Joint Select Committee on Deficit Reduction is mandated to produce its own list of cuts to the Me…
August 15, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XXVIII No. 11 – August 15, 2011 Issue
Last Friday, the acquisition of Southern Diagnostic Laboratories, Inc., of Birmingham, Alabama, was announced by Solstas Lab Partners of Greensboro, North Carolina. Steve Boyd, who is the Founder and CEO of Southern Diagnostics, will become a Senior Vice President at…
July 25, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 10 – July 25, 2011 Issue
In a play to expand its presence in cervical cancer testing, Roche Holdings announced an agreement to acquire mtm laboratories AG, based in Heidelberg, Germany. Roche will pay U.S. $180 million, plus another U.S. $85 million if performance milestones are achieved. mt…
July 05, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 9 – July 5, 2011 Issue
Two laboratory companies based in Spokane, Washington, were recently recognized in a list of Washington State’s “100 Best Companies to Work For” in 2011. One was Incyte Pathology, Inc., an anatomic pathology group. The other was Pathology Associates Medical Laboratori…
June 13, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 8 – June 13, 2011 Issue
In coming weeks, Agendia, probably best known for its genetic breast cancer test, hopes to complete an initial public offering (IPO). Agendia is a company based in Amsterdam, The Netherlands with offices in Irvine, California. Its stock symbol will be “AGDX” and the shares will t…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized